Obada Abou-Assali

Obada Abou-Assali

Auto-generated profile, based on publicly available information

Obada Abou-Assali

Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, FL, United States

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
BCBojjibabu Chidipi
Bojjibabu Chidipi
MCMengmeng Chang
Mengmeng Chang
MCMeng Cui
Meng Cui
OAObada Abou-Assali
Obada Abou-Assali
MRMichelle Reiser
Michelle Reiser
SNSami Noujaim
Sami Noujaim
We engineered and produced an ion channel blocking peptibody, that targets the acetylcholine-activated inwardly rectifying potassium current (IKACh). Peptibodies are chimeric proteins generated by fusing a biologically active peptide with the fragment crystallizable (Fc) region of the human immunoglobulin G (IgG). The IKAChblocking peptibody was engineered as a fusion between the human IgG1 Fc fragment and the IKAChinhibitor tertiapinQ (TP), a 21-amino acid synthetic peptidotoxin, originally isolated from the European honey bee venom. The peptibody was purified from the culture supernatant of human embryonic kidney (HEK) cells transfected with the peptibody construct. We tested the hypothesis that the bioengineered peptibody is bioactive and a potent blocker of IKACh. In HEK cells transfected with Kir3.1 and Kir3.4, the molecular correlates of IKACh, patch clamp showed that the peptibody was ~300-fold more potent than TP. Molecular dynamics simulations suggested that the increased potency could be due to an increased stabilization of the complex formed by peptibody-Kir3.1/3.4 channels compared to tertiapin-Kir3.1/3.4 channels. In isolated mouse myocytes, the peptibody blocked carbachol (Cch)-activated IKAChin atrial cells but did not affect the potassium inwardly rectifying background current in ventricular myocytes. In anesthetized mice, the peptibody abrogated the bradycardic effects of intraperitoneal Cch injection. Moreover, in aged mice, the peptibody reduced the inducibility of atrial fibrillation, likely via blocking constitutively active IKACh. Bioengineered anti-ion channel peptibodies can be powerful and highly potent ion channel blockers, with the potential to guide the development of modulators of ion channels or antiarrhythmic modalities.

8 September 2025 in Heart Rhythm
Verified
Journal Article
Open access
OAObada Abou-Assali
Obada Abou-Assali
BCBojjibabu Chidipi
Bojjibabu Chidipi
MCMengmeng Chang
Mengmeng Chang
MRMichelle Reiser
Michelle Reiser
RARyan Asswaytte
Ryan Asswaytte
SNSami Noujaim
Sami Noujaim
Electronic nicotine delivery systems (ENDS) utilize "E-liquids" in order to generate "E-vapor", an inhalable aerosolized mixture containing nicotine and flavors. Flavored ENDS are very popular among teens who vape, however, the possible cardiac electrophysiological harm of inhalation exposure to flavored ENDS are not fully understood. To test if inhalation exposure to flavoring carbonyls in e-liquids compromises mitochondrial integrity, increases oxidative stress, and leads to cardiac electrophysiological toxicity. Gas chromatography mass spectrometry (GC/MS), and flow cytometry, oxygen consumption rate measurement, in-vivo programmed electrical stimulation (PES), and multielectrode array (MEA) were used in atrial like HL-1 myocytes, hiPSC derived cardiomyocytes, and in mice overexpressing the antioxidant mitochondrial catalase (MCAT) exposed to flavored E-vapor. We compared the toxicity of E-vapor exposure from 30 differently flavored E-liquids (70% vegetable glycerin, 30% propylene glycol, with 6 mg/ml nicotine) in HL-1 cells using apoptotic annexin V flow cytometry. The toxicity of most E-liquids was significantly higher than air control. We subsequently determined the composition and quantified the concentrations of major flavoring carbonyls (cinnamaldehyde, vanillin, ethyl vanillin, maltol, and ethyl maltol) in the E-liquids using GC/MS. Linear regression analysis showed that toxicity correlated significantly with carbonyls concentration. We then measured in HL-1 cells exposed to vanilla flavored E-vapor reactive oxygen species (ROS) and mitochondrial membrane potential (ΔΨ) with CellROX and TMRE flow cytometry, respectively. ROS increased in exposed cells but this was prevented by N-acetylcycteine antioxidant pretreatment, and ΔΨ was depolarized in exposed cells. In-vivo inhalation exposure to vanilla flavored E-vapor increased the duration of PES induced ventricular tachycardia in WT but not in MCAT mice, compared to air controls. Finally, MEA recordings in hiPSC derived cardiomyocytes monolayers exposed to vanilla flavored E-vapor, with or without nicotine, resulted in decreased activation time, and increased corrected field potential duration. Inhalation exposure to flavored ENDS negatively affects ventricular electrophysiology, in part via adverse mitochondrial remodeling, and increased oxidative stress.

3 June 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
OAObada J. Abou-Assali
Obada J. Abou-Assali
MRMichelle Reiser
Michelle Reiser
MCMengmeng Chang
Mengmeng Chang
BCBojjibabu Chidipi
Bojjibabu Chidipi
RARyan Asswaytte
Ryan Asswaytte
SNSami Noujaim
Sami Noujaim
Background Electronic nicotine delivery systems (ENDS) heat “E-liquids” to generate “E-vapor”, an aerosolized mixture containing nicotine and flavors. Flavored ENDS are popular among teens who vape, however, the possible cardiac electrophysiological harm of inhalation exposure to flavored ENDS are not fully understood. Objective To test if inhalation exposure to flavoring carbonyls in E-liquids compromises mitochondrial integrity, increases oxidative stress, and leads to cardiac electrophysiological toxicity. Methods Gas chromatography mass spectrometry (GC/MS), flow cytometry, oxygen consumption rate (OCR) measurement, in-vivo programmed electrical stimulation (PES), and multielectrode array (MEA) were used in atrial like HL-1 myocytes, hiPSC derived cardiomyocytes, and mice overexpressing mitochondrial catalase (mCAT). Results We compared the toxicity of E-vapor exposure from 30 differently flavored E-liquids in HL-1 cells using apoptotic annexin V flow cytometry. Most E-liquids were toxic. We identified the major flavoring carbonyls in these E-liquids and quantified their concentrations using GC/MS. Linear regression analysis showed that toxicity correlated with carbonyls concentration. Using flow cytometry of CellROX and TMRE staining, HL-1 cells exposed to flavored E-vapor showed increased reactive oxygen species and depolarized mitochondrial membrane potential. Additionally, exposure decreased OCR in these cells. In-vivo inhalation exposure to flavored E-vapor increased the inducible ventricular tachycardia duration in WT but not in mCAT mice compared to controls. MEA recordings in hiPSC derived cardiomyocytes exposed to flavored E-vapor, with or without nicotine, resulted in changes in the spontaneous beating rate. Conclusions Inhalation exposure to flavored ENDS negatively affects ventricular electrophysiology, in part via adverse mitochondrial remodeling, and increased oxidative stress.